Steward Partners Investment Advisory’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.5K Hold
350
﹤0.01% 3675
2026
Q1
$12.4K Sell
350
-1
-0.3% -$41 ﹤0.01% 3463
2025
Q4
$14.3K Buy
351
+1
+0.3% +$44 ﹤0.01% 3288
2025
Q3
$16.5K Sell
350
-19
-5% -$985 ﹤0.01% 3171
2025
Q2
$19.2K Hold
369
﹤0.01% 2940
2025
Q1
$22.3K Sell
369
-2
-0.5% -$129 ﹤0.01% 2762
2024
Q4
$25.4K Sell
371
-9
-2% -$627 ﹤0.01% 2673
2024
Q3
$27.3K Sell
380
-102
-21% -$7.2K ﹤0.01% 2518
2024
Q2
$33.4K Buy
482
+68
+16% +$4.96K ﹤0.01% 2294
2024
Q1
$33.2K Sell
414
-40
-9% -$3.56K ﹤0.01% 2303
2023
Q4
$49.7K Buy
454
+104
+30% +$10.8K ﹤0.01% 2000
2023
Q3
$35.3K Hold
350
﹤0.01% 2068
2023
Q2
$47.6K Hold
350
﹤0.01% 1907
2023
Q1
$36.4K Hold
350
﹤0.01% 1992
2022
Q4
$31K Hold
350
﹤0.01% 2030
2022
Q3
$28K Hold
350
﹤0.01% 2058
2022
Q2
$34K Hold
350
﹤0.01% 1978
2022
Q1
$52K Hold
350
﹤0.01% 1887
2021
Q4
$50K Hold
350
﹤0.01% 1905
2021
Q3
$46K Hold
350
﹤0.01% 1943
2021
Q2
$48K Hold
350
﹤0.01% 3508
2021
Q1
$45.7K Hold
350
﹤0.01% 2034
2020
Q4
$39K Hold
350
﹤0.01% 1781
2020
Q3
$28K Buy
+350
New +$28.5K ﹤0.01% 1753

Other funds holding CNMD

Steward Partners Investment Advisory's CNMD Position: Q2 2026 in Review

Steward Partners Investment Advisory held its CONMED (CNMD) position steady in Q2 2026 at 350 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3675.

Steward Partners Investment Advisory first reported a position in CNMD in Q3 2020 and has held it in 24 quarters since. The position peaked at $52K in Q1 2022. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Steward Partners Investment Advisory held 350 shares of CONMED worth $11.5K as of Q2 2026.
  • Steward Partners Investment Advisory left its CONMED share count unchanged in Q2 2026.
  • CONMED made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #3675 holding.
  • Steward Partners Investment Advisory first reported a position in CONMED in Q3 2020 and has held it in 24 quarters since.
  • Steward Partners Investment Advisory's CONMED position peaked at $52K in Q1 2022.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.